Skip to content

A clinical trial to evaluate the efficacy of Panchamrut Parpati in management of Grahani ( Irritable Bowel Syndrome)

A Study to evaluate the efficacy of Panchamrut Parpati in management of Grahani W.S.R to Irritable Bowel Syndrome: A Placebo-controlled Single- Blind Randomised clinical trial. - Nil

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/07/055048
Enrollment
60
Registered
2023-07-11
Start date
Unknown
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K928- Other specified diseases of the digestive system

Interventions

None listed

Sponsors

Shri Krishna Govt. Ayurvedic College and Hospital, Kurukshetra, Haryana
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. the patient presented with cardinal features of Grahani roga as described in Ayurvedic texts. 2. Randomly selected irrespective of their cast, religion and sex. 3. Patients with the age group of 19-60 years. 4. Willing and able to participate in the study.

Exclusion criteria

Exclusion criteria: 1. The patient below 19 years and above 60 years of age. 2. Patients suffering from Gastritis, Intestinal obstructions, Intestinal tuberculosis, Ulcerative colitis and other abdominal disorders. 3. Patients suffering from major systemic illnesses necessitating long term drug treatment like Hyperthyroidism, inflammatory bowel disease, tuberculosis, uncontrolled diabetes, Hypertension, Psycho neuro endocrinal disorders. 4. Patients with concurrent serious hepatic/ renal disorders, severe pulmonary dysfunction or any type of malignancies. 5. Patient on prolonged ( > 6 weeks ) medication with corticosteroids, anti depressants, anticholinergics etc. 6. Alcoholics and any other drug abusers. 7. Pregnant and lactating women.

Design outcomes

Primary

MeasureTime frame
change in Subjective and Objective criteria of Grahani Roga. Timepoint: Treatment Duration- 28 Days

Secondary

MeasureTime frame
1. To study the effect of Drug & Placebo on clinical parameters & Biochemical findings associated with Grahani Roga. 2. Assess the effect of the trial drug in improving the quality of life of patients of Grahani roga. 3. To advise preventive measures to check the occurrence of disease in individuals & masses. 4. Provide an easy & cost-effective treatment for the patients of Grahani roga. 5. To standardize an Ayurvedic line of treatment both Drug & Dose which may have an effective role in the management of Patients of Grahani Roga. 6. To explain the Grahani roga on the basis of a critical review of the classic text of Ayurveda & with the help of Modern Literature.Timepoint: 2 years

Countries

India

Contacts

Public ContactPreeti Gahalawat

Shri Krishna Govt. Ayurvedic College And Hospital, Kurukshetra, Haryana,

drlamba.neha@gmail.com9736333868

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 6, 2026